Possible involvement of oxido-nitrosative stress induced neuro-inflammatory cascade and monoaminergic pathway: Underpinning the correlation between nociceptive and depressive behaviour in a rodent model

Journal of Affective Disorders

Volumn 151, Issue 3, 2013, Pages 1041-1052

  Arora, Vipin ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Allodynia; Biogenic amines; IL 1 ; Pain depression dyad; Substance P; TNF

Indexed keywords

BERBERINE; CASPASE 3; DOPAMINE; DULOXETINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; SUBSTANCE P;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; FORCED SWIMMING TEST; HIPPOCAMPUS; HYPERALGESIA; IMMOBILITY; MALE; MONOAMINERGIC SYSTEM; NITROSATIVE STRESS; NOCICEPTION; NONHUMAN; OXIDATIVE STRESS; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; RODENT MODEL;

ALLODYNIA; BIOGENIC AMINES; IL-1Β; PAIN-DEPRESSION DYAD; SUBSTANCE P; TNF-Α;

ANIMALS; BERBERINE; CASPASE 3; CEREBRAL CORTEX; DEPRESSION; DISEASE MODELS, ANIMAL; DOPAMINE; HIPPOCAMPUS; HYPERALGESIA; INTERLEUKIN-1BETA; MALE; NF-KAPPA B; NITRITES; NOCICEPTION; NOREPINEPHRINE; OXIDATIVE STRESS; PAIN; RATS, WISTAR; RESERPINE; SEROTONIN; SIGNAL TRANSDUCTION; SUBSTANCE P; SUPEROXIDE DISMUTASE;

EID: 84886719947     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.08.032     Document Type: Article

References (67)

1. B.A. Arnow, E.M. Hunkeler, C.M. Blasey, J. Lee, M.J. Constantino, B. Fireman, H.C. Kraemer, R. Dea, R. Robinson, and C. Hayward Comorbid depression, chronic pain, and disability in primary care Psychosomatic Medicine 68 2006 262 268
2. V. Arora, A. Kuhad, V. Tiwari, and K. Chopra Curcumin ameliorates reserpine-induced pain-depression dyad: behavioural, biochemical, neurochemical and molecular evidences Psychoneuroendocrinology 36 2011 1570 1581
3. S. Bagis, L. Tamer, G. Sahin, R. Bilgin, H. Guler, B. Ercan, and C. Erdogan Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatology International 25 2005 188 190
4. W.M. Bahk, S. Park, D.I. Jon, B.H. Yoon, K.J. Min, and J.P. Hong Relationship between painful physical symptoms and severity of depressive symptomatology and suicidality Psychiatry Research 189 2011 357 361
5. P. Blier, G. Gobbi, N. Haddjeri, L. Santarelli, G. Mathew, and R. Hen Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response Journal of Psychiatry & Neuroscience 29 2004 208 218
6. M.E. Burger, A. Alves, L. Callegari, F.R. Athayde, C.W. Nogueira, G. Zeni, and J.B. Rocha Ebselen attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum Progress in Neuro-Psychopharmacology & Biological Psychiatry 27 2003 135 140
7. V. Chan-Palay, G. Jonsson, and S.L. Palay Serotonin and substance P coexist i, neurons of the rat's central nervous system Proceedings of the National Academy of Sciences of the United States of America 75 1978 1582 1586
8. Claiborne, A.; 1985. Catalase Activity. CRC Handbook of Methods for Oxygen Radical Research 284.
9. M.D. Cordero, A.M. Moreno-Fernandez, M. Demiguel, P. Bonal, F. Campa, L.M. Jimenez-Jimenez, A. Ruiz-Losada, B. Sanchez-Dominguez, J.A.S. Alcazar, L. Salviati, and P. Navas Coenzyme Q10 distribution in blood is altered in patients with Fibromyalgia Clinical Biochemistry 42 2009 732 735
10. J. Dersh, P.B. Polatin, and R.J. Gatchel Chronic pain and psychopathology: research findings and theoretical considerations Psychosomatic Medicine 64 2002 773 786
11. Y. Dowlati, N. Herrmann, W. Swardfager, H. Liu, L. Sham, E.K. Reim, and K.L. Lanctot A meta-analysis of cytokines in major depression Biological Psychiatry 67 2010 446 457
12. K. Eide, and K. Hole Interactions between substance P and norepinephrine in the regulation of nociception in mouse spinal cord Pharmacology and Toxicology 70 1992 397 401
13. D.L. Goldenberg Pain/depression dyad: a key to a better understanding and treatment of functional somatic syndromes American Journal of Medicine 123 2010 675 682
14. T. Greco, G. Eckert, and K. Kroenke The outcome of physical symptoms with treatment of depression Journal of General Internal Medicine 19 2004 813 818
15. L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum Analysis of nitrate, nitrite, and [15 N]nitrate in biological fluids Analytical Biochemistry 126 1982 131 138
16. B.P. Guiard, M. El Mansari, and P. Blier Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors Current Drug Targets 10 2009 1069 1084
17. O. Gureje, M. Von Korff, L. Kola, K. Demyttenaere, Y.L. He, J. Posada-Villa, J.P. Lepine, M.C. Angermeyer, D. Levinson, G. de Girolamo, N. Iwata, A. Karam, G.L.G. Borges, R. de Graaf, M.O. Browne, D.J. Stein, J.M. Haro, E.J. Bromet, R.C. Kessler, and J. Alonso The relation between multiple pains and mental disorders: results from the World Mental Health Surveys Pain 135 2008 82 91
18. M.K. Hahn, and M.J. Bannon Tachykinin NK1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus European Journal of Pharmacology 348 1998 155 160
19. P. Henningsen, and B. Lowe Depression, pain, and somatoform disorders Current Opinion in Psychiatry 19 2006 19 24
20. H. Herken, A. Gurel, S. Selek, F. Armutcu, M.E. Ozen, M. Bulut, O. Kap, M. Yumru, H.A. Savas, and O. Akyol Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment Archives of Medical Research 38 2007 247 252
21. T. Hokfelt, D. Millhorn, K. Seroogy, Y. Tsuruo, S. Ceccatelli, B. Lindh, B. Meister, T. Melander, M. Schalling, and T. Bartfai Coexistence of peptides with classical neurotransmitters Experientia 43 1987 768 780
22. Q.J. Huang, H. Jiang, X.L. Hao, and T.R. Minor Brain IL-1 beta was involved in reserpine-induced behavioral depression in rats Acta Pharmacologica Sinica 25 2004 293 296
23. D.J. Jollow, J.R. Mitchell, N. Zampaglione, and J.R. Gillette Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite Pharmacology 11 1974 151 169
24. H. Kim, L. Chen, G. Lim, B. Sung, S. Wang, M.F. McCabe, G. Rusanescu, L. Yang, Y. Tian, and J. Mao Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression Journal of Clinical Investigation 122 2012 2940 2954
25. L.D. Kong, C.H. Cheng, and R.X. Tan Monoamine oxidase inhibitors from rhizoma of Coptis chinensis Planta Medica 67 2001 74 76
26. Y. Kono Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase Archives of Biochemistry and Biophysics 186 1978 189 195
27. M.S. Kramer, N. Cutler, J. Feighner, R. Shrivastava, J. Carman, J.J. Sramek, S.A. Reines, G. Liu, D. Snavely, E. Wyatt-Knowles, J.J. Hale, S.G. Mills, M. MacCoss, C.J. Swain, T. Harrison, R.G. Hill, F. Hefti, E.M. Scolnick, M.A. Cascieri, G.G. Chicchi, S. Sadowski, A.R. Williams, L. Hewson, D. Smith, E.J. Carlson, R.J. Hargreaves, and N.M. Rupniak Distinct mechanism for antidepressant activity by blockade of central substance P receptors Science 281 1998 1640 1645
28. K. Kroenke Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management International Journal of Methods in Psychiatric Research 12 2003 34 43
29. S.K. Kulkarni, and A. Dhir Possible involvement of l-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride European Journal of Pharmacology 569 2007 77 83
30. S.K. Kulkarni, and A. Dhir On the mechanism of antidepressant-like action of berberine chloride European Journal of Pharmacology 589 2008 163 172
31. S.K. Kulkarni, and R.K. Robert Reversal by serotonergic agents of reserpine-induced hyperalgesia in rats European Journal of Pharmacology 83 1982 325 328
32. E. Kupeli, M. Kosar, E. Yesilada, K. Husnu, and C. Baser A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species Life Science 72 2002 645 657
33. L. Kuznetsova, E. Sochilina, M. Faddeeva, and O. Iagodina Effect of some isoquinoline alkaloids on enzymatic activity of acetylcholinesterase and monoamine oxidase Ukrainskii biokhimicheskii zhurnal 77 2005 147
34. A.A. Larson, S.L. Giovengo, I.J. Russell, and J.E. Michalek Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways Pain 87 2000 201 211
35. P. Lee, M. Zhang, J.P. Hong, H.C. Chua, K.P. Chen, S.W. Tang, B.T. Chan, M.S. Lee, B. Lee, G.L. Gallagher, and M. Dossenbach Frequency of painful physical symptoms with major depressive disorder in asia: relationship with disease severity and quality of life Journal of Clinical Psychiatry 70 2009 83 91
36. A.F. Leuchter, M.M. Husain, I.A. Cook, M.H. Trivedi, S.R. Wisniewski, W.S. Gilmer, J.F. Luther, M. Fava, and A.J. Rush Painful physical symptoms and treatment outcome in major depressive disorder: a STARD (Sequenced Treatment Alternatives to Relieve Depression) report Psychological Medicine 40 2010 239 251
37. N. Li, and M. Karin Is NF-κB the sensor of oxidative stress? The FASEB Journal 13 1999 1137 1143
38. W. Liu, P. Liu, S. Tao, Y. Deng, X. Li, T. Lan, X. Zhang, F. Guo, W. Huang, F. Chen, H. Huang, and S.F. Zhou Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose Archives of Biochemistry and Biophysics 475 2008 128 134
39. J.B. Lohr, R. Kuczenski, and A.B. Niculescu Oxidative mechanisms and tardive dyskinesia CNS Drugs 17 2003 47 62
40. M. Maes, P. Galecki, Y.S. Chang, and M. Berk A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness Progress in Neuro-Psychopharmacology & Biological Psychiatry 35 2011 676 692
41. T. Oe, M. Tsukamoto, and Y. Nagakura Reserpine causes biphasic nociceptive sensitivity alteration in conjunction with brain biogenic amine tones in rats Neuroscience 169 2010 1860 1871
42. M.M. Ohayon, and A.F. Schatzberg Using chronic pain to predict depressive morbidity in the general population Archives of General Psychiatry 60 2003 39 47
43. M.M. Ohayon, and A.F. Schatzberg Chronic pain and major depressive disorder in the general population Journal of Psychiatric Research 44 2010 454 461
44. S. Omoigui The biochemical origin of pain: the origin of all pain is inflammation and the inflammatory response. Part 2 of 3 - Inflammatory profile of pain syndromes Medical Hypotheses 69 2007 1169 1178
45. B.A. Patel, M. Arundell, K.H. Parker, M.S. Yeoman, and D. O'Hare Simple and rapid determination of serotonin and catecholamines in biological tissue using high-performance liquid chromatography with electrochemical detection Journal of Chromatography B - Analytical Technologies in the Biomedical and Life Sciences 818 2005 269 276
46. G. Pelletier, H.W. Steinbusch, and A.A. Verhofstad Immunoreactive substance P and serotonin present in the same dense-core vesicles Nature 293 1981 71 72
47. W.H. Peng, K.L. Lo, Y.H. Lee, T.H. Hung, and Y.C. Lin Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice Life Science 81 2007 933 938
48. R.D. Porsolt, M. Le Pichon, and M. Jalfre Depression: a new animal model sensitive to antidepressant treatments Nature 266 1977 730 732
49. J. Prins, B. Olivier, and S.M. Korte Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited Expert Opinion on Investigational Drugs 20 2011 1107 1130
50. L. Rackova, M. Majekova, D. Kost'alova, and M. Stefek Antiradical and antioxidant activities of alkaloids isolated from Mahonia aquifolium. Structural aspects Bioorganic & Medicinal Chemistry 12 2004 4709 4715
51. C.L. Raison, L. Capuron, and A.H. Miller Cytokines sing the blues: inflammation and the pathogenesis of depression Trends in Immunology 27 2006 24 31
52. A. Remppis, F. Bea, H.J. Greten, A. Buttler, H. Wang, Q. Zhou, M.R. Preusch, R. Enk, R. Ehehalt, H. Katus, and E. Blessing Rhizoma coptidis inhibits LPS-induced MCP-1/CCL2 production in murine macrophages via an AP-1 and NFkappaB-dependent pathway Mediators of Inflammation 2010 2010 194896
53. M.B. Rosenberg, F.I. Carroll, and S.S. Negus Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats Journal of Pain 3 2013 246 249
54. A. Sarandol, E. Sarandol, S.S. Eker, S. Erdinc, E. Vatansever, and S. Kirli Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems Human Psychopharmacology Clinical and Experimental 22 2007 67 73
55. R. Schreck, and P.A. Baeuerle [14] Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-κB Methods in Enzymology 234 1994 151 163
56. M.J. Schwarz, M. Spath, H. Muller-Bardorff, D.E. Pongratz, B. Bondy, and M. Ackenheil Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients Neuroscience Letters 259 1999 196 198
57. C.K. Sen, and L. Packer Antioxidant and redox regulation of gene transcription The FASEB Journal 10 1996 709 720
58. S. Stahl, and M. Briley Understanding pain in depression Human Psychopharmacology 19 Suppl. 1 2004 S9 S13
59. J. Szelenyi, J.P. Kiss, E. Puskas, M. Szelenyi, and E.S. Vizi Contribution of differently localized alpha 2- and beta-adrenoceptors in the modulation of TNF-alpha and IL-10 production in endotoxemic mice Annals of the New York Academy of Sciences 917 2000 145 153
60. N. Uceyler, T. Eberle, R. Rolke, F. Birklein, and C. Sommer Differential expression patterns of cytokines in complex regional pain syndrome Pain 132 2007 195 205
61. D.J. Wallace Is there a role for cytokine based therapies in fibromyalgia Current Pharmaceutical Design 12 2006 17 22
62. F.M. Werner, and R. Covenas Classical neurotransmitters and neuropeptides involved in major depression: a review International Journal of Neuroscience 120 2010 455 470
63. L.S. Williams, W.J. Jones, J. Shen, R.L. Robinson, and K. Kroenke Outcomes of newly referred neurology outpatients with depression and pain Neurology 63 2004 674 677
64. E.D. Wills Mechanisms of lipid peroxide formation in tissues. Role of metals and haematin proteins in the catalysis of the oxidation unsaturated fatty acids Biochimica et Biophysica Acta 98 1965 238 251
65. M. Yanik, O. Erel, and M. Kati The relationship between potency of oxidative stress and severity of depression Acta Neuropsychiatrica 16 2004 200 203
66. E. Yesilada, and E. Kupeli Berberis crataegina DC. root exhibits potent anti-inflammatory, analgesic and febrifuge effects in mice and rats Journal of Ethnopharmacology 79 2002 237 248
67. X.Q. Zhou, X.N. Zeng, H. Kong, and X.L. Sun Neuroprotective effects of berberine on stroke models in vitro and in vivo Neuroscience Letters 447 2008 31 36